IGF1 and hyperinsulinemic hypoglycemia, familial, 4: Given the extensive safety data of IGF-1 therapy for IGF-1 deficiency-related short stature and a recent RTT study, IGF-1 is a good potential candidate for controlled trials in ASD [112,113].